top of page
FDA Approved: New Long-Acting PrEP Regimen and Its Implications
In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...
Jun 23, 202530 min read
Beyond Borders: Internationalization Strategies for Health Startups
In recent years, I’ve had the privilege of closely following the birth and growth of dozens of health startups, both in Brazil and...
Apr 7, 20253 min read
The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read
bottom of page